171 related articles for article (PubMed ID: 22175655)
1. Measuring Alzheimer disease progression with transition probabilities: estimates from NACC-UDS.
Spackman DE; Kadiyala S; Neumann PJ; Veenstra DL; Sullivan SD
Curr Alzheimer Res; 2012 Nov; 9(9):1050-8. PubMed ID: 22175655
[TBL] [Abstract][Full Text] [Related]
2. Relationships of change in Clinical Dementia Rating (CDR) on patient outcomes and probability of progression: observational analysis.
Tariot PN; Boada M; Lanctôt KL; Hahn-Pedersen J; Dabbous F; Udayachalerm S; Raket LL; Halchenko Y; Michalak W; Weidner W; Cummings J
Alzheimers Res Ther; 2024 Feb; 16(1):36. PubMed ID: 38355706
[TBL] [Abstract][Full Text] [Related]
3. Estimating Alzheimer's Disease Progression Rates from Normal Cognition Through Mild Cognitive Impairment and Stages of Dementia.
Davis M; O Connell T; Johnson S; Cline S; Merikle E; Martenyi F; Simpson K
Curr Alzheimer Res; 2018; 15(8):777-788. PubMed ID: 29357799
[TBL] [Abstract][Full Text] [Related]
4. CDR state transition probabilities in Alzheimer's disease with and without cholinesterase inhibitor intervention in an observational cohort.
Bloudek LM; Spackman DE; Veenstra DL; Sullivan SD
J Alzheimers Dis; 2011; 24(3):599-607. PubMed ID: 21297268
[TBL] [Abstract][Full Text] [Related]
5. Measuring Alzheimer's disease progression with transition probabilities: estimates from CERAD.
Neumann PJ; Araki SS; Arcelus A; Longo A; Papadopoulos G; Kosik KS; Kuntz KM; Bhattacharjya A
Neurology; 2001 Sep; 57(6):957-64. PubMed ID: 11571317
[TBL] [Abstract][Full Text] [Related]
6. Estimating Progression Rates Across the Spectrum of Alzheimer's Disease for Amyloid-Positive Individuals Using National Alzheimer's Coordinating Center Data.
Potashman M; Buessing M; Levitchi Benea M; Cummings J; Borson S; Pemberton-Ross P; Epstein AJ
Neurol Ther; 2021 Dec; 10(2):941-953. PubMed ID: 34431074
[TBL] [Abstract][Full Text] [Related]
7. Measuring Alzheimer's disease progression with transition probabilities in the Taiwanese population.
Fuh JL; Pwu RF; Wang SJ; Chen YH
Int J Geriatr Psychiatry; 2004 Mar; 19(3):266-70. PubMed ID: 15027042
[TBL] [Abstract][Full Text] [Related]
8. Resource utilisation, costs and clinical outcomes in non-institutionalised patients with Alzheimer's disease: 18-month UK results from the GERAS observational study.
Lenox-Smith A; Reed C; Lebrec J; Belger M; Jones RW
BMC Geriatr; 2016 Nov; 16(1):195. PubMed ID: 27887645
[TBL] [Abstract][Full Text] [Related]
9. Longitudinal Neuropsychological Outcome in Taiwanese Alzheimer's Disease Patients Treated with Medication.
Yang YH; Wu MN; Chou PS; Su HC; Lin SH; Sung PS
Curr Alzheimer Res; 2018 Mar; 15(5):474-481. PubMed ID: 29032750
[TBL] [Abstract][Full Text] [Related]
10. Estimating Transition Probabilities Across the Alzheimer's Disease Continuum Using a Nationally Representative Real-World Database in the United States.
Tahami Monfared AA; Fu S; Hummel N; Qi L; Chandak A; Zhang R; Zhang Q
Neurol Ther; 2023 Aug; 12(4):1235-1255. PubMed ID: 37256433
[TBL] [Abstract][Full Text] [Related]
11. Validation of the new interpretive guidelines for the clinical dementia rating scale sum of boxes score in the national Alzheimer's coordinating center database.
O'Bryant SE; Lacritz LH; Hall J; Waring SC; Chan W; Khodr ZG; Massman PJ; Hobson V; Cullum CM
Arch Neurol; 2010 Jun; 67(6):746-9. PubMed ID: 20558394
[TBL] [Abstract][Full Text] [Related]
12. Costs and Resource Use Associated with Alzheimer's Disease in Italy: Results from an Observational Study.
Bruno G; Mancini M; Bruti G; Dell'Agnello G; Reed C
J Prev Alzheimers Dis; 2018; 5(1):55-64. PubMed ID: 29405234
[TBL] [Abstract][Full Text] [Related]
13. Longitudinal Sensitivity of Alzheimer's Disease Severity Staging.
Benoit JS; Chan W; Piller L; Doody R
Am J Alzheimers Dis Other Demen; 2020; 35():1533317520918719. PubMed ID: 32573256
[TBL] [Abstract][Full Text] [Related]
14. Cholinesterase Inhibitors May Not Benefit Mild Cognitive Impairment and Mild Alzheimer Disease Dementia.
Han JY; Besser LM; Xiong C; Kukull WA; Morris JC
Alzheimer Dis Assoc Disord; 2019; 33(2):87-94. PubMed ID: 30633043
[TBL] [Abstract][Full Text] [Related]
15. Timing of Dysphagia Screening in Alzheimer's Dementia.
Özsürekci C; Arslan SS; Demir N; Çalışkan H; Şengül Ayçiçek G; Kılınç HE; Yaşaroğlu ÖF; Kızılarslanoğlu C; Tuna Doğrul R; Balcı C; Sümer F; Karaduman A; Yavuz BB; Cankurtaran M; Halil MG
JPEN J Parenter Enteral Nutr; 2020 Mar; 44(3):516-524. PubMed ID: 31172554
[TBL] [Abstract][Full Text] [Related]
16. Comparing measures of decline to dementia in amnestic MCI subjects in the National Alzheimer's Coordinating Center (NACC) Uniform Data Set.
Monsell SE; Liu D; Weintraub S; Kukull WA
Int Psychogeriatr; 2012 Oct; 24(10):1553-60. PubMed ID: 22717299
[TBL] [Abstract][Full Text] [Related]
17. Progression of Alzheimer's disease during a three-year follow-up using the CERAD-NB total score: Kuopio ALSOVA study.
Hallikainen I; Hänninen T; Fraunberg M; Hongisto K; Välimäki T; Hiltunen A; Karppi P; Sivenius J; Soininen H; Koivisto AM;
Int Psychogeriatr; 2013 Aug; 25(8):1335-44. PubMed ID: 23676340
[TBL] [Abstract][Full Text] [Related]
18. Revised criteria for mild cognitive impairment may compromise the diagnosis of Alzheimer disease dementia.
Morris JC
Arch Neurol; 2012 Jun; 69(6):700-8. PubMed ID: 22312163
[TBL] [Abstract][Full Text] [Related]
19. Predicting the progression of Alzheimer's disease dementia: A multidomain health policy model.
Green C; Zhang S
Alzheimers Dement; 2016 Jul; 12(7):776-85. PubMed ID: 27016691
[TBL] [Abstract][Full Text] [Related]
20. Health economic effect of donepezil treatment for CDR 0.5 converters to Alzheimer's disease as shown by the Markov model.
Kasuya M; Meguro K
Arch Gerontol Geriatr; 2010; 50(3):295-9. PubMed ID: 19481822
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
